𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The anti-interleukin-1 in type 1 diabetes action trial—background and rationale

✍ Scribed by Linda M.S. Pickersgill; Thomas R. Mandrup-Poulsen

Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
73 KB
Volume
25
Category
Article
ISSN
1520-7552

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Anti-ganglioside autoantibodies in type
Anti-ganglioside autoantibodies in type 1 diabetes
✍ Marta Lucchetta; Salvatore Rudilosso; Silvana Costa; Daniela Bruttomesso; Susann 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 66 KB

## Abstract Type 1 diabetes is an autoimmune disease that is accompanied by an immune response against pancreatic cells. As gangliosides are expressed in both peripheral nerves and pancreatic cells, we examined the possibility of correlation between type 1 diabetes, anti‐ganglioside autoantibodies,

Type 1 diabetes—not all in the genes
Type 1 diabetes—not all in the genes
✍ David Leslie 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 38 KB

## Abstract The incidence of autoimmune diseases is appreciable and increasing. Type 1 diabetes is one such disease, and is, in part, determined genetically, involving many genes (up to 40 at the last count), but they alone cannot account for the frequency of the disease, indicating that non‐geneti